Clinical trial
Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis
NCT06456489 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis
- Lead sponsor
- Sohag University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 1, 2024
- Completion date
- December 31, 2024
- Enrollment
- 268 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
active rheumatoid arthritis